Trial intelligence / Profile preview

Effect of Motilitone on Gastric Emptying Time After Distal Gastrectomy (MOGEDIG)

KCT0004084Phase 4Completed

Sponsor
Dong-A ST
Start
Apr 2018
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Motilitone in gastric cancer (GC), sponsored by Dong-A ST. Started Apr 2018; status: completed.

02

Drugs

Motilitone
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on KCT0004084.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0004084.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call